263 related articles for article (PubMed ID: 25463412)
1. The utility of galectin-3 for predicting cause-specific death in hospitalized patients with heart failure.
Zhang Y; Zhang R; An T; Huang Y; Guo X; Yin S; Wang Y; Ji S; Lv R; Zhang J; Maisel A
J Card Fail; 2015 Jan; 21(1):51-9. PubMed ID: 25463412
[TBL] [Abstract][Full Text] [Related]
2. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of galectin-3 on admission in Chinese patients with heart failure: a prospective observational study.
Wang H; Chen Q; Li Y; Jing X; Liang T; Yang J
Acta Cardiol; 2017 Apr; 72(2):188-195. PubMed ID: 28597803
[TBL] [Abstract][Full Text] [Related]
4. Serial galectin-3 and future cardiovascular disease in the general population.
van der Velde AR; Meijers WC; Ho JE; Brouwers FP; Rienstra M; Bakker SJ; Muller Kobold AC; van Veldhuisen DJ; van Gilst WH; van der Harst P; de Boer RA
Heart; 2016 Jul; 102(14):1134-41. PubMed ID: 27084804
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Serial Galectin-3 Measurements in Patients With Acute Heart Failure.
van Vark LC; Lesman-Leegte I; Baart SJ; Postmus D; Pinto YM; de Boer RA; Asselbergs FW; Wajon EMCJ; Orsel JG; Boersma E; Hillege HL; Akkerhuis KM;
J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29187387
[TBL] [Abstract][Full Text] [Related]
6. Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study.
Felker GM; Fiuzat M; Shaw LK; Clare R; Whellan DJ; Bettari L; Shirolkar SC; Donahue M; Kitzman DW; Zannad F; Piña IL; O'Connor CM
Circ Heart Fail; 2012 Jan; 5(1):72-8. PubMed ID: 22016505
[TBL] [Abstract][Full Text] [Related]
7. Utility of galectin-3 as a prognostic biomarker in heart failure: where do we stand?
Srivatsan V; George M; Shanmugam E
Eur J Prev Cardiol; 2015 Sep; 22(9):1096-110. PubMed ID: 25268020
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure.
Ahmad T; Fiuzat M; Neely B; Neely ML; Pencina MJ; Kraus WE; Zannad F; Whellan DJ; Donahue MP; Piña IL; Adams KF; Kitzman DW; O'Connor CM; Felker GM
JACC Heart Fail; 2014 Jun; 2(3):260-8. PubMed ID: 24952693
[TBL] [Abstract][Full Text] [Related]
9. Estimating systemic fibrosis by combining galectin-3 and ST2 provides powerful risk stratification value for patients after acute decompensated heart failure.
Wang CH; Yang NI; Liu MH; Hsu KH; Kuo LT
Cardiol J; 2016; 23(5):563-572. PubMed ID: 27515479
[TBL] [Abstract][Full Text] [Related]
10. Impact of diabetes on the predictive value of heart failure biomarkers.
Alonso N; Lupón J; Barallat J; de Antonio M; Domingo M; Zamora E; Moliner P; Galán A; Santesmases J; Pastor C; Mauricio D; Bayes-Genis A
Cardiovasc Diabetol; 2016 Nov; 15(1):151. PubMed ID: 27809845
[TBL] [Abstract][Full Text] [Related]
11. Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure.
van Kimmenade RR; Januzzi JL; Ellinor PT; Sharma UC; Bakker JA; Low AF; Martinez A; Crijns HJ; MacRae CA; Menheere PP; Pinto YM
J Am Coll Cardiol; 2006 Sep; 48(6):1217-24. PubMed ID: 16979009
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of serum galectin-3 levels in patients with acute heart failure with preserved ejection fraction.
Carrasco-Sánchez FJ; Aramburu-Bodas O; Salamanca-Bautista P; Morales-Rull JL; Galisteo-Almeda L; Páez-Rubio MI; Arias-Jiménez JL; Aguayo-Canela M; Pérez-Calvo JI
Int J Cardiol; 2013 Nov; 169(3):177-82. PubMed ID: 24207066
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Serial Measurements of Soluble Suppression of Tumorigenicity 2 and Galectin-3 in Ambulatory Patients With Chronic Heart Failure.
Miller WL; Saenger AK; Grill DE; Slusser JP; Bayes-Genis A; Jaffe AS
J Card Fail; 2016 Apr; 22(4):249-55. PubMed ID: 26277907
[TBL] [Abstract][Full Text] [Related]
14. Galectin-3: a new biomarker for the diagnosis, analysis and prognosis of acute and chronic heart failure.
Hrynchyshyn N; Jourdain P; Desnos M; Diebold B; Funck F
Arch Cardiovasc Dis; 2013 Oct; 106(10):541-6. PubMed ID: 24090952
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH.
van der Velde AR; Gullestad L; Ueland T; Aukrust P; Guo Y; Adourian A; Muntendam P; van Veldhuisen DJ; de Boer RA
Circ Heart Fail; 2013 Mar; 6(2):219-26. PubMed ID: 23395934
[TBL] [Abstract][Full Text] [Related]
16. Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: a pooled analysis of 3 clinical trials.
Meijers WC; Januzzi JL; deFilippi C; Adourian AS; Shah SJ; van Veldhuisen DJ; de Boer RA
Am Heart J; 2014 Jun; 167(6):853-60.e4. PubMed ID: 24890535
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of plasma soluble ST2 in hospitalized Chinese patients with heart failure.
Zhang R; Zhang Y; Zhang J; An T; Huang Y; Guo X; Januzzi JL; Cappola TP; Yin S; Wang Y; Zhou Q; Zou C; Ji S; Lv R
PLoS One; 2014; 9(10):e110976. PubMed ID: 25347817
[TBL] [Abstract][Full Text] [Related]
18. Comparison of multiple biomarkers for mortality prediction in patients with acute heart failure of ischemic and nonischemic etiology.
Zhang M; Meng Q; Qi X; Han Q; Qi X; Wang F; Du B
Biomark Med; 2018 Nov; 12(11):1207-1217. PubMed ID: 30499308
[TBL] [Abstract][Full Text] [Related]
19. Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT.
Anand IS; Rector TS; Kuskowski M; Adourian A; Muntendam P; Cohn JN
Eur J Heart Fail; 2013 May; 15(5):511-8. PubMed ID: 23291728
[TBL] [Abstract][Full Text] [Related]
20. Role of galectin-3 and plasma B type-natriuretic peptide in predicting prognosis in discharged chronic heart failure patients.
Feola M; Testa M; Leto L; Cardone M; Sola M; Rosso GL
Medicine (Baltimore); 2016 Jun; 95(26):e4014. PubMed ID: 27368017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
